Scalper1 News
Wall Street was scrambling to assess the impact on drug stocks of the closing of a tax loophole known as “double Irish,” proposed by the Irish government Tuesday. The issue is a different one from the overall lower corporate tax rates in Ireland, which have driven the controversial tax-inversion deals that have relocated a number of U.S. companies to Ireland. The double Irish involves shifting untaxed revenue to an Irish subsidiary and eventually Scalper1 News
Scalper1 News